Tag: Jemperli endometrial cancer

Home / Jemperli endometrial cancer

Categories

Dostarlimab-gxly with chemotherapy is approved by the FDA for endometrial cancer

August 2023: Dostarlimab-gxly (Jemperli, GlaxoSmithKline), followed by dostarlimab-gxly as a single agent, was approved by the Food and Drug Administration for the treatment of primary advanced or re...
jemperli-endometrial-cancer

Scan the code